SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-073063
Filing Date
2022-06-21
Accepted
2022-06-21 17:19:05
Documents
12
Period of Report
2022-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2219040d1_8k.htm   iXBRL 8-K 23305
  Complete submission text file 0001104659-22-073063.txt   196125

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kprx-20220616.xsd EX-101.SCH 3048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kprx-20220616_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kprx-20220616_pre.xml EX-101.PRE 22605
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2219040d1_8k_htm.xml XML 3721
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 221029095
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences